MORTALITY-RATES AMONG THE LONDON COHORT OF THE WHO MULTINATIONAL STUDY OF VASCULAR-DISEASE IN DIABETIC-PATIENTS

被引：0
|
作者：
MORRISH, NJ
STEVENS, LK
FULLER, JH
JARRETT, RJ
KEEN, H
机构：
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,METAB MED UNIT,LONDON,ENGLAND
[2] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT COMMUNITY MED,LONDON,ENGLAND
[3] UNIV LONDON UNIV COLL,DEPT COMMUNITY MED,LONDON WC1E 6BT,ENGLAND
来源：
DIABETOLOGIA | 1989年 / 32卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：A519 / A519
页数：1
相关论文
共 50 条
  • [11] CLINICAL-STUDY OF BRADILAN (TETRANICOTINOYLFRUCTOSE) IN DIABETIC-PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    BORODA, C
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1975, 3 (01) : 10 - 11
  • [12] LIPID AND LIPOPROTEIN ABNORMALITIES IN DIABETIC-PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    LAAKSO, M
    PYORALA, K
    ATHEROSCLEROSIS, 1988, 74 (1-2) : 55 - 63
  • [13] INCIDENCE AND PREVALENCE OF CLINICAL PERIPHERAL VASCULAR-DISEASE IN A POPULATION-BASED COHORT OF DIABETIC-PATIENTS
    MELTON, LJ
    MACKEN, KM
    PALUMBO, PJ
    ELVEBACK, LR
    DIABETES CARE, 1980, 3 (06) : 650 - 654
  • [14] THE DETERMINANTS OF PROTEINURIA AMONG DIABETICS - THE WHO MULTINATIONAL STUDY OF VASCULAR-DISEASE IN DIABETES, WARSAW RESULTS
    JANECZKO, D
    KROLEWSKI, AS
    DIABETOLOGIA, 1980, 19 (03) : 285 - 285
  • [15] STUDY OF FIBRINOLYTIC SYSTEM IN NON-INSULIN DIABETIC-PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    MARCO, P
    VELASCO, J
    PICO, A
    LUCAS, J
    CALATAYUD, R
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 795 - 795
  • [16] BLOOD-PRESSURE, PROTEINURIA AND THEIR RELATIONSHIP WITH CIRCULATORY MORTALITY - THE WHO MULTINATIONAL STUDY OF VASCULAR-DISEASE IN DIABETICS
    FULLER, JH
    HEAD, J
    DIABETES & METABOLISM, 1989, 15 (5BIS): : 273 - 277
  • [17] THE PREVALENCE OF PERIPHERAL VASCULAR-DISEASE IN SULFONYLUREA TREATED DIABETIC-PATIENTS WITH PROTEINURIA
    MIGDALIS, IN
    KOURTI, A
    VOUDOURIS, G
    LIKOUDI, A
    SAMARTZIS, M
    INTERNATIONAL ANGIOLOGY, 1990, 9 (04) : 271 - 273
  • [18] WHICH DIABETIC-PATIENTS SHOULD BE TAKING ASPIRIN - THOSE WITH VASCULAR-DISEASE AND THOSE AT GREATLY INCREASED RISK OF VASCULAR-DISEASE
    YUDKIN, JS
    BMJ-BRITISH MEDICAL JOURNAL, 1995, 311 (7006): : 641 - 642
  • [19] MORTALITY AND MORBIDITY ASSOCIATED WITH BODY-WEIGHT IN PEOPLE WITH IDDM - THE WHO MULTINATIONAL STUDY OF VASCULAR-DISEASE IN DIABETES
    CHATURVEDI, N
    STEVENS, LK
    FULLER, JH
    JARRETT, RJ
    KEEN, H
    MORRISH, NJ
    WATKINS, PJ
    TEUSCHER, A
    TEUSCHER, T
    STUDER, PP
    DIEM, P
    CZYZYK, A
    JANECZKO, D
    KOPCZYNSKI, J
    RASKOVIC, M
    SCHLIACK, V
    RATZMANN, KP
    AGANOVIC, I
    SKRABOLO, A
    STAVLJENIC, A
    ROGLIC, G
    YOUNG, RTT
    LAM, K
    MA, J
    KOSAKA, K
    MIKI, E
    DEACOSTA, OM
    AMARO, S
    DIAZ, O
    HANG, M
    QUESDA, X
    YERO, AH
    LEE, E
    BENNETT, PH
    PETTITT, DJ
    NELSON, RG
    DIABETES CARE, 1995, 18 (06) : 761 - 765
  • [20] APOLIPOPROTEIN-E POLYMORPHISM AS A RISK FACTOR FOR VASCULAR-DISEASE IN DIABETIC-PATIENTS
    BOEMI, M
    SIROLLA, C
    AMADIO, L
    FUMELLI, P
    POMETTA, D
    JAMES, RW
    DIABETES CARE, 1995, 18 (04) : 504 - 508
12345